American Portfolios Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

American Portfolios Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$8.48K	Hold	150	–	–	﹤0.01%	2598
2022 Q2	$9.58K	Hold	150	–	–	﹤0.01%	2589
2022 Q1	$9.71K	Hold	150	–	–	﹤0.01%	2702
2021 Q4	$9.98K	Hold	150	–	–	﹤0.01%	2615
2021 Q3	$9.16K	Buy	+150	New	+$9.54K	﹤0.01%	2612
2020 Q1	–	Sell	-96	Closed	-$5.12K	–	2844
2019 Q4	$5.12K	Buy	+96	New	+$4.73K	﹤0.01%	2269

Other funds holding IHE

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

American Portfolios Advisors's IHE Position: Q3 2022 in Review

American Portfolios Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q3 2022 at 150 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

American Portfolios Advisors first reported a position in IHE in Q4 2019 and has held it in 6 quarters since. The position peaked at $9.98K in Q4 2021. 113 funds tracked by Wall St. Rank hold IHE as of Q3 2022.

American Portfolios Advisors held 150 shares of iShares US Pharmaceuticals ETF worth $8.48K as of Q3 2022.
American Portfolios Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q3 2022.
iShares US Pharmaceuticals ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2598 holding.
American Portfolios Advisors first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and has held it in 6 quarters since.
American Portfolios Advisors's iShares US Pharmaceuticals ETF position peaked at $9.98K in Q4 2021.
113 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.